AHNTI EU Agenda (FULL BACKUP) | Kisaco Research

AHNTI EU Agenda (FULL BACKUP)

Agenda Days: 
  • Mon, Mar 2: Workshops: Monday, 2 Mar, 2026
    8:30am - 9:00am
    9:00am - 10:30am
    Workshops

    WORKSHOP

    Time: 
    9.00am - 10.30am
    Agenda Track No.: 
    Track 8
    Summary: 
    Details to be announced shortly
    Session Type: 
    General Session (Presentation)

    ROUNDTABLE: AI and Innovation - How companies are using AI to discover new technologies for livestock health

    Key discussions points

    • Predictive disease modelling and early detection
    • AI to support smarter vaccine development and deployment
    • Interpretation of complex biological data (omics)
    • Training LLMs to summarize complex topics and specialized literature
    • Current AI-based tools for patent search and discovery
    Sponsor(s): 
    United Animal Health
    Speaker(s): 

    Author:

    Sebastiano Busato

    Associate Research Scientist
    United Animal Health
    ... read more

    Sebastiano Busato

    Associate Research Scientist
    United Animal Health

    Author:

    Nathan Horn

    Scientific Discovery Lead
    United Animal Health
    ... read more

    Nathan Horn

    Scientific Discovery Lead
    United Animal Health
    Time: 
    9.30am-10.30am
    Agenda Track No.: 
    Track 9
    Session Type: 
    General Session (Presentation)
    10:45am - 12:15pm
    Workshops

    WORKSHOP

    Sponsor(s): 
    Paul Dick and Associates
    Speaker(s): 

    Author:

    Paul Dick

    President
    Paul Dick & Associates

    Dr Paul Dick D.V.M. M.Sc. obtained his veterinary medical degree with honours in 1984.

    While working in clinical practice he completed his Masters in Immunology and Virology transitioning into the Pharmaceutical industry in 1988. Dr. Dick has over 25 years experience in the pharmaceutical space including general management and leadership roles, business development, commercialization, regulatory affairs, and product development encompassing medicinal, non-medicinal and natural health products.

    His work in this sector has ranged from small “start up” companies to medium and large multi-nationals functioning in various capacities from research to COO and CEO.

    Dr. Dick has worked extensively with Health Canada and the Canadian Food Inspection Agency on numerous regulatory submissions and on several Departmental Committees.

    In addition he has been a recipient of the NSERC Synergy Award and has served as a peer reviewer of NSERC strategic grants. He is currently heading his own consulting firm ( Paul Dick and Associates Ltd.) and is the managing partner and president of a venture capital partnership (Vet Venture Capital Inc.).

    ... read more

    Paul Dick

    President
    Paul Dick & Associates

    Dr Paul Dick D.V.M. M.Sc. obtained his veterinary medical degree with honours in 1984.

    While working in clinical practice he completed his Masters in Immunology and Virology transitioning into the Pharmaceutical industry in 1988. Dr. Dick has over 25 years experience in the pharmaceutical space including general management and leadership roles, business development, commercialization, regulatory affairs, and product development encompassing medicinal, non-medicinal and natural health products.

    His work in this sector has ranged from small “start up” companies to medium and large multi-nationals functioning in various capacities from research to COO and CEO.

    Dr. Dick has worked extensively with Health Canada and the Canadian Food Inspection Agency on numerous regulatory submissions and on several Departmental Committees.

    In addition he has been a recipient of the NSERC Synergy Award and has served as a peer reviewer of NSERC strategic grants. He is currently heading his own consulting firm ( Paul Dick and Associates Ltd.) and is the managing partner and president of a venture capital partnership (Vet Venture Capital Inc.).

    Time: 
    10.45am - 12.15pm
    Agenda Track No.: 
    Track 7
    Session Type: 
    General Session (Presentation)

    WORKSHOP

    Sponsor(s): 
    MSD Animal Health
    Time: 
    10.45am - 12.15pm
    Agenda Track No.: 
    Track 8
    Summary: 
    Details to be announced shortly
    Session Type: 
    General Session (Presentation)

    ROUNDTABLE

    Sponsor(s): 
    Clinglobal
    Speaker(s): 

    Author:

    Dr. Kimberly Simmons

    Director Global Regulatory Affairs
    Clinglobal
    ... read more

    Dr. Kimberly Simmons

    Director Global Regulatory Affairs
    Clinglobal
    Time: 
    10.45am - 11.45am
    Agenda Track No.: 
    Track 9
    Session Type: 
    General Session (Presentation)
    12:30pm - 2:00pm
    Workshops

    WORKSHOP

    Time: 
    12.30pm - 2.00pm
    Agenda Track No.: 
    Track 7
    Summary: 
    Details to be announced shortly
    Session Type: 
    General Session (Presentation)

    WORKSHOP

    Sponsor(s): 
    AskVet
    Speaker(s): 

    Author:

    Cal Lai

    Chairman & CEO
    Ask.vet



    ... read more

    Cal Lai

    Chairman & CEO
    Ask.vet



    Time: 
    12.30pm - 2.00pm
    Agenda Track No.: 
    Track 8
    Session Type: 
    General Session (Presentation)

    ROUNDTABLE

    Time: 
    12.30pm - 1.30pm
    Agenda Track No.: 
    Track 9
    Summary: 
    Details to be announced shortly
    Session Type: 
    General Session (Presentation)
    10.15am - 12.30pm
    Investor Briefing (For Investors Only)

    Investor Briefing Part I: State of the Industry - Factors fuelling growth and deal flow

    Industry partners most heavily involved in transactions across the ecosystem will share a data driven view of the market and discuss activity over the last 5 years and what we can expect in the next 5.

    Speaker(s): 
    Moderator

    Author:

    Robert Darwin

    Partner
    Sidley Austin LLP
    ... read more

    Robert Darwin

    Partner
    Sidley Austin LLP
    Time: 
    10.15am - 11.15am
    Agenda Track No.: 
    Track 11
    Summary: 
    For Investors Only
    Session Type: 
    General Session (Presentation)

    Investor Briefing Part II: Navigating Opportunities in Animal Health: Biopharma, Nutrition, Diagnostics and Technology

    Our panel of experienced animal health investors and deal makers will discuss their investment thesis, commercialisation and exit strategies.

    Speaker(s): 
    Panellists

    Author:

    Spencer Swayze

    Managing Director
    Osiris Growth Capital
    ... read more

    Spencer Swayze

    Managing Director
    Osiris Growth Capital

    Author:

    Dave Ross

    Partner
    Agrifood Investment Advisory LLP
    ... read more

    Dave Ross

    Partner
    Agrifood Investment Advisory LLP

    Author:

    Wendy Furness

    Director & Founder
    Animal Health Angels
    ... read more

    Wendy Furness

    Director & Founder
    Animal Health Angels

    Author:

    Julia Stephanus

    Partner
    Borealis Ventures

    Julia has been a visionary entrepreneur and strategic brand builder in the veterinary industry for 30+ years. Her achievements include building and scaling two successful start-up veterinary pharmaceutical businesses and launching 28 veterinary products.  She was Founder and CEO of Summit VetPharm, which exited to Ceva Animal Health in 2010.  As Chief Commercial Officer of Aratana Therapeutics (PETX), she was instrumental in the IPO and the buildout of a fully integrated commercial organization.  Julia led the co-promotion and the licensing of Aratana’s lead osteoarthritis product, Galliprant®, to Elanco.  Aratana exited to Elanco in 2019.

    Julia is Founder and President of Avviare, LLC, providing consulting services to start-ups and established players in veterinary biopharmaceuticals.  In addition to the start-up experience, Julia’s career includes senior-level positions at Ceva, Forest Laboratories (Allergan) and Pfizer Animal Health (Zoetis) and their legacy companies.

    Julia presently serves on the Boards of PBI Gordon, ReduxBio, and Jenga Biosciences.  Julia is a Founding Director and Board Member of Feather in Her Cap, recognizing outstanding women in Animal Health.  

    Julia received her Bachelor of Arts from Indiana University in Bloomington, Indiana, with additional education at the Wharton School of Business, Columbia University, the University of Chicago, and Harvard University.

    ... read more

    Julia Stephanus

    Partner
    Borealis Ventures

    Julia has been a visionary entrepreneur and strategic brand builder in the veterinary industry for 30+ years. Her achievements include building and scaling two successful start-up veterinary pharmaceutical businesses and launching 28 veterinary products.  She was Founder and CEO of Summit VetPharm, which exited to Ceva Animal Health in 2010.  As Chief Commercial Officer of Aratana Therapeutics (PETX), she was instrumental in the IPO and the buildout of a fully integrated commercial organization.  Julia led the co-promotion and the licensing of Aratana’s lead osteoarthritis product, Galliprant®, to Elanco.  Aratana exited to Elanco in 2019.

    Julia is Founder and President of Avviare, LLC, providing consulting services to start-ups and established players in veterinary biopharmaceuticals.  In addition to the start-up experience, Julia’s career includes senior-level positions at Ceva, Forest Laboratories (Allergan) and Pfizer Animal Health (Zoetis) and their legacy companies.

    Julia presently serves on the Boards of PBI Gordon, ReduxBio, and Jenga Biosciences.  Julia is a Founding Director and Board Member of Feather in Her Cap, recognizing outstanding women in Animal Health.  

    Julia received her Bachelor of Arts from Indiana University in Bloomington, Indiana, with additional education at the Wharton School of Business, Columbia University, the University of Chicago, and Harvard University.

    Time: 
    11.30am - 12.30pm
    Agenda Track No.: 
    Track 11
    Session Type: 
    General Session (Presentation)
    10.15am - 12.30pm
    Practice Group Leaders AI & Data Briefing

    Practice Group AI & Data Briefing Part I: R&D Collaborations

    Speaker(s): 
    Panellists

    Author:

    Dan O'Neil

    Associate Professor in Companion Animal Epidemiology
    Royal Veterinary College, University of London
    ... read more

    Dan O'Neil

    Associate Professor in Companion Animal Epidemiology
    Royal Veterinary College, University of London

    Author:

    David Singleton

    Director of Research
    IVC Evidensia
    ... read more

    David Singleton

    Director of Research
    IVC Evidensia
    Time: 
    10.15am - 11.15am
    Agenda Track No.: 
    Track 12
    Session Type: 
    General Session (Presentation)
    12:00pm
    12:40pm - 3:55pm
  • Mon, Mar 2: Main Event: Monday, 2 Mar, 2026
    12:00pm
    12:40pm - 1.00pm
    One-to-One Meetings + Next Stages

    Meeting Timeslot One

    Time: 
    12.40pm - 1.00pm
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One: Navigating Corporate Turnaround to Achieve Sustainable Growth

    Scaling beyond limited early-stage momentum often calls for a disciplined corporate turnaround strategy. Jake Burlet outlines the practical steps CanBiocin took to shift from grant-to-grant R&D survival to a profitable growing enterprise through securing strategic investment.

    Session Topics: 
    2022 Showcase Finalist
    Nutrition
    Companion and Livestock
    Microbiome
    Prevention
    Series B
    Milestone - Corporate Turnaround
    Speaker(s): 

    Author:

    Jake Burlet

    CEO
    CanBiocin
    ... read more

    Jake Burlet

    CEO
    CanBiocin
    Time: 
    12:40pm - 1:00pm
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two: Leveraging Direct-to-Consumer Tools to Transform the Veterinary Care Model

    Evolving pet owner expectations demand new models of engagement. Susan Groeneveld shares how Sylvester.AI is pioneering direct-to-consumer pathways to connect with owners, strengthen veterinary partnerships, and unlock commercial scale. 

    Session Topics: 
    2022 Showcase Finalist
    Technology
    Feline
    Pain
    Diagnosis
    Monitoring
    Series A
    Revenue Generating
    Milestone - Route to Market
    Speaker(s): 

    Author:

    Susan Groeneveld

    Founder
    sylvester.ai
    ... read more

    Susan Groeneveld

    Founder
    sylvester.ai
    Time: 
    12:40pm - 1:00pm
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    1.05pm - 1.25pm
    One-to-One Meetings + Next Stages

    Meeting Timeslot Two

    Time: 
    1.05pm - 1.25pm
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One: Navigating Bridge Finance to Secure an Oversubscribed Funding Round

    A well-timed bridge investment can mean the difference between stalling and scaling. Dr. Asel Sartbaeva, CEO and co-founder of EnsiliTech, reflects on how family office support provided crucial bridge, enabled better deal terms, and positioned the company to close an oversubscribed £4.5 million round.

    Session Topics: 
    2024 Showcase Finalist
    Milestone - Bridge Funding
    Funding
    Family Office
    Companion and Livestock
    Biopharma
    Seed
    Prevention
    Treatment
    Speaker(s): 

    Author:

    Asel Sartbaeva

    CEO
    EnsiliTech
    ... read more

    Asel Sartbaeva

    CEO
    EnsiliTech
    Time: 
    1.05pm - 1.25pm
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    1.05pm - 1.25pm
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    1:30pm - 1:50pm
    One-to-One Meetings + Next Stages

    Meeting Timeslot Three

    Time: 
    1:30pm - 1:50pm
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One: Leveraging AI Driven Open Platforms to Engage Livestock Producers, Distributors & Researchers

    Scaling livestock technology requires uniting innovation with effective distribution and farmer adoption. David Smith outlines how Ceres Tag’s open platform empowers universities, distributors, and next-generation producers to accelerate global adoption and data-driven impact.

    Session Topics: 
    2021 Showcase Finalist
    Milestone - AI to Engage Customers
    Technology
    Livestock
    Monitoring
    AI
    Partnerships
    Farmer
    Customer Adoption
    Late Stage VC
    Detection
    Prevention
    Distribution
    Speaker(s): 

    Author:

    Mr. David Smith

    CEO & Executive Chair
    Ceres Tag
    ... read more

    Mr. David Smith

    CEO & Executive Chair
    Ceres Tag
    Time: 
    1:30pm - 1:50pm
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    1:30pm - 1:50pm
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    1:55pm - 2:15pm
    One-to-One Meetings + Next Stages

    Meeting Timeslot Four

    Time: 
    1.55pm - 2.15pm
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One: Navigating the Commercialisation of Novel Cancer Therapies Amidst a Developing Regulatory Landscape

    When innovation moves faster than policy, the path to market calls for creative approaches. Tammie Wahaus, CEO of ELIAS Animal Health, shares how her team advances pivotal trials, adapts human health technologies, and keeps development on track as regulatory expectations continue to evolve.

    Session Topics: 
    Biopharma
    USDA
    Oncology
    Canine
    Regulation
    Immunotherapy
    Treatment
    Companion
    Milestone - Shifting Regulatory Landscape
    Speaker(s): 

    Author:

    Tammie Wahaus

    Chief Executive Officer
    ELIAS Animal Health
    ... read more

    Tammie Wahaus

    Chief Executive Officer
    ELIAS Animal Health
    Time: 
    1:55pm - 2:15pm
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    1:55pm - 2:15pm
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    2.20pm - 2.40pm
    One-to-One Meetings + Next Stages

    Meeting Slot Five

    Time: 
    2.20pm - 2.40pm
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One: Navigating Non-Dilutive Capital to Commercialise Livestock Technology

    Securing non-dilutive capital can be the key to bridging the gap between research and commercial reality for agtech startups. Matt Dobbs shares how AgSenze leveraged grant programmes including Innovate UK and EU Horizon to de-risk R&D, unlock private investment, and provide a launchpad of scaling HerdVision.

    Session Topics: 
    Milestone - Non-Dilutive Capital
    Technology
    Monitoring
    Government Funding
    Detection
    Treatment
    Series A
    Grant
    Livestock
    Speaker(s): 

    Author:

    Matt Dobbs

    Chief Executive Officer
    AGSENZE Ltd
    ... read more

    Matt Dobbs

    Chief Executive Officer
    AGSENZE Ltd
    Time: 
    2.20pm - 2.40pm
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    2.20pm - 2.40pm
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    2.45pm - 3.05pm
    One-to-One Meetings + Next Stages

    Meeting Slot Six

    Time: 
    2.45pm - 3.05pm
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One: Navigating Veterinary Education to Achieve Adoption of a New Category of Care

    Commercialising a new category of care requires more than product innovation. Rebecca Windsor, Director of Veterinary Affairs at Gallant, shares how education and developing trusted continuing education platforms have been central to preparing veterinarians for the clinical adoption of regenerative medicine.

    Session Topics: 
    2022 Showcase Finalist
    Milestone - Veterinary Engagement
    Biopharma
    Companion
    Canine
    Feline
    Chronic Disease
    Treatment
    Speaker(s): 

    Author:

    Rebecca Windsor

    Director of Veterinary Affairs
    Gallant
    ... read more

    Rebecca Windsor

    Director of Veterinary Affairs
    Gallant
    Time: 
    2.45pm - 3.05pm
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    2.45pm - 3.05pm
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    3.10pm - 3.30pm
    One-to-One Meetings + Next Stages

    Meeting Slot Seven

    Time: 
    3.10pm - 3.30pm
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One

    Time: 
    3.10pm - 3.30pm
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    3.10pm - 3.30pm
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    3.35pm - 3.55pm
    One-to-One Meetings + Next Stages

    Meeting Slot Eight

    Time: 
    3.35pm - 3.55pm
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One

    Time: 
    3.35pm - 3.55pm
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    3.35pm - 3.55pm
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    4:05pm - 6:35pm
    2026 Innovation Showcase

    Showcase Finalists: Eight Pitches

    Finalists will be selected by our esteemed Selection Committee from Biopharma, Nutrition, Diagnostics and Technology application categories. Our Finalist Founders will provide a 5 minute pitch to our main stage audience of strategic partners, investors and fellow founders, with 5 minutes for live Q&A with the judges panel. 

    Time: 
    4:05pm - 5:15pm
    Session Type: 
    General Session (Presentation)

    Rest Break

    Time: 
    5:15pm - 5:25pm
    Session Type: 
    General Session (Presentation)

    Showcase Finalists: Eight Pitches

    Finalists will be selected by our esteemed Selection Committee from Biopharma, Nutrition, Diagnostics and Technology application categories. Our Finalist Founders will provide a 5 minute pitch to our main stage audience of strategic partners, investors and fellow founders, with 5 minutes for live Q&A with the judges panel.

    Time: 
    5:25pm - 6:35pm
    Session Type: 
    General Session (Presentation)
    6:35pm - 7:35pm
    Social
    7:35pm onwards
    Social
  • Tues Mar 3: Main Event: Tuesday, 3 Mar, 2026
    8:00am
    8:30am - 10:20am
    Plenaries

    Opening Keynote

    Sponsor(s): 
    Zoetis
    Time: 
    8:40am - 9:00am
    Session Type: 
    General Session (Presentation)

    Presentation

    Sponsor(s): 
    Stonehaven Cozmix Group
    Speaker(s): 

    Author:

    Matthias Hofer

    Managing Partner
    Stonehaven Cozmix Group

    Matthias Hofer is the Managing Partner at Stonehaven Consulting AG with over 15 years of experience in Animal Health. He served on the executive committees of two major Animal Health companies for a total of 7 years. Between 2009 and 2013 he led the global Aqua Health business at Novartis Animal Health (NAH). Later on, he was Global Leader Emerging Business at Elanco and a member of Elanco’s global executive committee. During 2014 and with Elanco’s intention to buy NAH, Matthias served as overall pre-merger integration leader on the Novartis side. In that role, Matthias led a large team and efforts to prepare integration pre-closing overall including carve-out preparations of operations linked to Novartis.

    ... read more

    Matthias Hofer

    Managing Partner
    Stonehaven Cozmix Group

    Matthias Hofer is the Managing Partner at Stonehaven Consulting AG with over 15 years of experience in Animal Health. He served on the executive committees of two major Animal Health companies for a total of 7 years. Between 2009 and 2013 he led the global Aqua Health business at Novartis Animal Health (NAH). Later on, he was Global Leader Emerging Business at Elanco and a member of Elanco’s global executive committee. During 2014 and with Elanco’s intention to buy NAH, Matthias served as overall pre-merger integration leader on the Novartis side. In that role, Matthias led a large team and efforts to prepare integration pre-closing overall including carve-out preparations of operations linked to Novartis.

    Author:

    Chad Terrell

    Head of Business Development
    Stonehaven Cozmix Group
    ... read more

    Chad Terrell

    Head of Business Development
    Stonehaven Cozmix Group
    Time: 
    9:05am - 9:25am
    Session Type: 
    General Session (Presentation)

    PANEL: Commercialisation Journeys – Strategic Alliances and Partnerships

    Given the complexity and cost of the commercialisation journey, strategic alliances and partnerships become a key decision for all founders. This panel will discuss the who, the why, and perhaps most crucially the decision around when to partner.

    • Improving capital efficiency within the animal health market
    • Factors to consider when evaluating and planning route to market
    • How strategic partners will leverage data and AI to help guide start-ups and speed to commercialisation
    • Drivers of successful partnerships and the realisation of value
    Speaker(s): 
    Panellists

    Author:

    Megan Grether

    Head of Global Business Development and Licensing Animal Health
    Boehringer Ingelheim
    ... read more

    Megan Grether

    Head of Global Business Development and Licensing Animal Health
    Boehringer Ingelheim

    Author:

    Jim McIntyre

    Head of Global Business Development
    Merck Animal Health
    ... read more

    Jim McIntyre

    Head of Global Business Development
    Merck Animal Health
    Time: 
    9:30am - 10:00am
    Session Type: 
    General Session (Presentation)

    Presentation

    Winners will be announced from the following categories

    • Best-in-Class from Biopharma, Nutrition, Diagnostics and Technology
    • The Calan Smith Award for Innovation
    • Audience Best in Show Award
    • Judges Best in Show Award

    Speaker(s): 
    Time: 
    10:05am - 10:25am
    Summary: 
    Held for Partner
    Session Type: 
    General Session (Presentation)
    10:20am - 10:30am
    10:30am - 10:50am
    One-to-One Meetings + Next Stages

    Meeting Timeslot Nine

    Time: 
    10:30am - 10:50am
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One: Leveraging Platform Innovation for Fast, Field-Matched Vaccines

    Breaking into the animal health vaccines market requires overcoming high regulatory barriers and providing speed in response to outbreaks and evolving variants. Hanjo Hennemann shares how VEROVACCiNES leveraged a recombinant platform to rapidly design, test, and scale vaccines utilising regulatory pathways for broader and faster market entry.

    Session Topics: 
    Milestone - Platform Technology
    Vaccine
    Biopharma
    Livestock
    Late-Stage VC
    Regulation
    Speaker(s): 

    Author:

    Hanjo Hennemann

    CEO
    VEROVACCiNES
    ... read more

    Hanjo Hennemann

    CEO
    VEROVACCiNES
    Time: 
    10.30am - 10.50am
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    10.30am - 10.50am
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    10:55pm - 11.15pm
    One-to-One Meetings + Next Stages

    Meeting Timeslot Ten

    Time: 
    10:55am - 11:15am
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    10:55am - 11.15am
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    11.20am - 11.40am
    One-to-One Meetings + Next Stages

    Meeting Timeslot Eleven

    Time: 
    11.20am - 11.40am
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One: Leveraging Private Equity Backing to Achieve Scale in Nutritional Health

    Creating scale in nutritional health requires more than just a pipeline of products, it demands smart capital and commercial innovation. Bill Weldon shares how Axiota has successfully leveraged private equity backing to merge platforms, secure FDA approval, expand geographically, and ultimately scale into a profitable business.

    Session Topics: 
    Milestone - Private Equity Backing
    Livestock
    Prevention
    Nutrition
    Microbiome
    FDA
    Regulation
    Funding
    Speaker(s): 

    Author:

    William Weldon

    CEO
    Axiota
    ... read more

    William Weldon

    CEO
    Axiota
    Time: 
    11.20am - 11.40am
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    11.20am - 11.40am
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    11:45am - 1:00pm
    Plenaries

    From Human to Animal: Next Gen Therapeutics Shaping the Future of Health

    A sneak peek into cutting‑edge research and innovations driving next‑generation biopharma — from human health breakthroughs to translational applications in animal health. Explore novel compounds, delivery technologies and cross‑species strategies accelerating Animal Health

    Sponsor(s): 
    MSD Animal Health
    Speaker(s): 

    Author:

    Rob Kelly

    SVP, Global Marketing & Commercial Leader EURAM
    MSD Animal Health
    ... read more

    Rob Kelly

    SVP, Global Marketing & Commercial Leader EURAM
    MSD Animal Health
    Time: 
    11:45am - 12:05pm
    Session Type: 
    General Session (Presentation)

    PANEL: The Commercialisation Journey – Global perspectives on regulatory approval

    Bringing innovation to market means navigating complex and often fragmented regulatory pathways. This panel explores the regulatory hurdles that shape timelines, costs, and strategic choices, highlighting the global differences that influence market access. Panellists will also consider whether greater harmonisation across regions is possible, or even desirable, and what that could mean for innovators.

    Speaker(s): 
    Moderator

    Author:

    Chris Boyle

    Senior Managing Associate
    Sidley Austin LLP
    ... read more

    Chris Boyle

    Senior Managing Associate
    Sidley Austin LLP
    Panellists

    Author:

    Dr. Kimberly Simmons

    Director Global Regulatory Affairs
    Clinglobal
    ... read more

    Dr. Kimberly Simmons

    Director Global Regulatory Affairs
    Clinglobal

    Author:

    Roxanne Feller

    Secretary General
    Animal Health Europe
    ... read more

    Roxanne Feller

    Secretary General
    Animal Health Europe
    Time: 
    12:10pm - 12:40pm
    Session Type: 
    General Session (Presentation)

    AHNTI Showcase Winners Announcement

    Winners will be announced across the following categories

    • Best in Class across Biopharma, Nutrition, Diagnostics and Technology
      Best in Show – Judges Award
    • Best in Show – Audience Award
    • Calan Smith Innovation Award
    Speaker(s): 

    Author:

    Niamh Gallagher

    Program Director - AHNTI
    Kisaco Research
    ... read more

    Niamh Gallagher

    Program Director - AHNTI
    Kisaco Research
    Time: 
    12:45pm - 1:00pm
    Session Type: 
    General Session (Presentation)
    1:00pm - 2:00pm

    Lunch

    Session Type: 
    General Session (Presentation)
    2:05pm - 2:35pm
    Changemakers Stages A, B & C

    PANEL: Predictive AI in Livestock - Leveraging Technology to Improve Health and Productivity

    Artificial intelligence can play a vital role by enabling predictive analytics to help farmers anticipate productivity changes and prevent health issues before they escalate. Hear from the changemakers applying data-driven insights to deliver measurable health and productivity gains across livestock systems.

    • Demonstrating ROI – building the evidence base to drive farmer adoption
    • Data – overcoming the challenge of dispersed datasets from farms, labs and clinics
    • Route to market – integrating AI tools into existing farm management systems
    Speaker(s): 
    Panellists

    Author:

    Paul Horwood

    UK Head of Farm
    IVC Evidensia
    ... read more

    Paul Horwood

    UK Head of Farm
    IVC Evidensia

    Author:

    Robert Hyde

    Co-Founder and CTO
    Vet Vision AI
    ... read more

    Robert Hyde

    Co-Founder and CTO
    Vet Vision AI
    Time: 
    2:05pm - 2:35pm
    Agenda Track No.: 
    Track 4
    Session Type: 
    General Session (Presentation)

    PANEL: Defining the future of Regenerative Medicine - Cell and Gene Therapies and their Clinical Potential

    Cell and gene therapies are redefining the possibilities of veterinary medicine offering the potential to repair, replace, and restore biological function. With the first approvals expected as early as 2026, changemakers at the forefront of research and commercialisation explore the opportunities and hurdles that will define their path to clinical adoption.

    • Clinical adoption – building veterinary trust and integrating into practice workflows
    • Distribution – ensuring stability, scalability, and accessibility
    Speaker(s): 
    Panellists

    Author:

    Linda Black

    CEO
    Gallant Therapeutics
    ... read more

    Linda Black

    CEO
    Gallant Therapeutics

    Author:

    Thomas Koch

    Founder, CEO & CSO
    eQcell Inc
    ... read more

    Thomas Koch

    Founder, CEO & CSO
    eQcell Inc

    Author:

    Julia Loew

    Chief Commercial Officer
    MWI Animal Health
    ... read more

    Julia Loew

    Chief Commercial Officer
    MWI Animal Health
    Time: 
    2:05pm - 2:35pm
    Agenda Track No.: 
    Track 5
    Session Type: 
    General Session (Presentation)

    PANEL: Nutrition-based Therapies - Using Diet-Driven Approaches to Treat and Manage Companion Animal Health

    Nutrition-based therapies are redefining companion animal care, offering evidence-driven approaches to manage metabolic, inflammatory, and chronic conditions. With advances moving from research to practice, changemakers at the forefront of science and product development explore the opportunities and hurdles that will shape clinical validation, adoption, and long-term impact.

    • Clinical validation – generating evidence to secure veterinary confidence and consumer trust
    • Market adoption – positioning nutrition as a credible option to treat chronic disease
    Speaker(s): 
    Moderator

    Author:

    Julie Lawless

    President
    Lawless Strategic Communications
    ... read more

    Julie Lawless

    President
    Lawless Strategic Communications
    Time: 
    2:05pm - 2:35pm
    Agenda Track No.: 
    Track 6
    Session Type: 
    General Session (Presentation)
    2:40pm - 3:10pm
    Changemakers Stages A, B & C

    PANEL: Genetics and Genomics Decoded - Applications in Diagnostics, Disease Resistance, and Productivity

    Advances in genetics and genomics are enabling faster progress in productivity, welfare, and disease resistance across livestock species. Changemakers highlight the changemakers applying genomic selection, gene editing, and advanced breeding strategies to improve animal health outcomes and productivity.

    • Regulatory pathways – navigating approval and acceptance of genomic technologies
    • Market adoption – demonstrating value to farmers and integrating innovation into breeding programs
    Speaker(s): 
    Panellists

    Author:

    Dr Eve Hanks

    Chief Executive Officer & Founder
    MI:RNA Diagnostics
    ... read more

    Dr Eve Hanks

    Chief Executive Officer & Founder
    MI:RNA Diagnostics
    Time: 
    2:40pm - 3:10pm
    Agenda Track No.: 
    Track 4
    Session Type: 
    General Session (Presentation)

    PANEL: The Future of Parasiticides - Tackling Resistance for Long-Term Protection

    Veterinary associations recommend regular parasite control and diagnostics to prevent transmission. However, parasiticides face growing scrutiny over environmental and health concerns. With resistance increasing, changemakers are developing innovative solutions, ranging from new treatments to advanced diagnostics and targeted delivery, ensuring long-term protection for animals and humans.

    • Market differentiation – demonstrating value of novel products in a crowded market
    • Adoption hurdles – balancing efficacy, cost, and stewardship to drive uptake
    Speaker(s): 
    Moderator

    Author:

    Claire Fowler

    SVP Head of Global Strategic Marketing Animal Health,
    Boehringer Ingelheim

    After completing a degree in Veterinary Medicine at Cambridge University in 2002, her first professional experience was working in clinical veterinary practice before joining Boehringer Ingelheim in 2005. She subsequently completed an MBA at London Business School.

     

    In Boehringer Ingelheim she has held positions at a local, regional and global level across business management, marketing and technical functions, mainly in Animal Health. This includes senior leadership roles such as the responsibility for the Boehringer Ingelheim Italian animal health subsidiary, and most recently for the overall commercial performance of the region encompassing Europe and Canada.  She also spent some time in Consumer Health Care as Category lead in global marketing.

     

    Claire was appointed Head of Global Strategic Marketing in January 2025 and became a member of the Executive Committee of the Animal Health Business Unit at Boehringer.

    ... read more

    Claire Fowler

    SVP Head of Global Strategic Marketing Animal Health,
    Boehringer Ingelheim

    After completing a degree in Veterinary Medicine at Cambridge University in 2002, her first professional experience was working in clinical veterinary practice before joining Boehringer Ingelheim in 2005. She subsequently completed an MBA at London Business School.

     

    In Boehringer Ingelheim she has held positions at a local, regional and global level across business management, marketing and technical functions, mainly in Animal Health. This includes senior leadership roles such as the responsibility for the Boehringer Ingelheim Italian animal health subsidiary, and most recently for the overall commercial performance of the region encompassing Europe and Canada.  She also spent some time in Consumer Health Care as Category lead in global marketing.

     

    Claire was appointed Head of Global Strategic Marketing in January 2025 and became a member of the Executive Committee of the Animal Health Business Unit at Boehringer.

    Time: 
    2:40pm - 3:10pm
    Agenda Track No.: 
    Track 5
    Session Type: 
    General Session (Presentation)

    PANEL: Point-of-Care Diagnostics - Accelerating Decisions from Clinic to Farm

    Rapid diagnostics are transforming everyday veterinary practice, enabling earlier detection and faster decision-making. Changemakers explore the latest advances in point-of-care tools, their role in improving outcomes, and the challenges of validation, adoption, and integration into workflows.

    • Validation – generating clinical evidence to support regulatory approval and vet adoption
    • Integration – embedding diagnostics into workflows for scale and commercial uptake
    Speaker(s): 
    Moderator

    Author:

    Joe Harvey

    Head of Animal Health
    S&P Global
    ... read more

    Joe Harvey

    Head of Animal Health
    S&P Global
    Panellists

    Author:

    Richard Mellanby

    Global Head of Medical Innovation and Strategy
    IDEXX
    ... read more

    Richard Mellanby

    Global Head of Medical Innovation and Strategy
    IDEXX
    Time: 
    2:40pm - 3:10pm
    Agenda Track No.: 
    Track 6
    Session Type: 
    General Session (Presentation)
    3:15pm - 3:45pm
    Changemakers Stages A, B & C

    PANEL: Expanding the Toolkit - Preventative Strategies and Alternatives to tackle AMR

    Antimicrobial resistance is one of the most urgent challenges in animal and human health, demanding new approaches beyond traditional antibiotics. Changemakers developing preventative strategies and non-antibiotic alternatives explore the opportunities and hurdles that will define how these tools expand the veterinary toolkit, reduce dependence, and safeguard vital medicines.

    • Market positioning – differentiating alternatives from traditional antibiotics
    • Adoption drivers – proving cost-effectiveness and securing veterinary and farmer buy-in
    Speaker(s): 
    Panellists

    Author:

    Tom Weaver

    Co-Founder & Chairman
    PetMedix & ArkVax
    ... read more

    Tom Weaver

    Co-Founder & Chairman
    PetMedix & ArkVax
    Time: 
    3:15pm - 3:45pm
    Agenda Track No.: 
    Track 4
    Session Type: 
    General Session (Presentation)

    PANEL: Next-Generation Monoclonal Antibodies - Expanding Targets and Extending Impact

    Monoclonal antibodies are redefining therapeutic possibilities in animal health, offering precise, targeted alternatives to traditional treatments. With next-generation innovation expanding into new disease areas and species, changemakers at the forefront examine the opportunities and hurdles that will shape development, approval, and adoption.

    • Regulatory pathways – navigating approval processes for novel biologics
    • Clinical adoption – driving veterinary education and confidence in new therapies
    Time: 
    3:15pm - 3:45pm
    Agenda Track No.: 
    Track 5
    Session Type: 
    General Session (Presentation)

    PANEL: Prevention First: The Role of Nutrition in Building Resilient Animal Health Systems

    Nutrition is emerging as a powerful tool for preventing disease and strengthening immunity in livestock. Changemakers leading this shift explore the opportunities and hurdles that will shape evidence generation, farmer adoption, and the scaling of preventative nutrition across global production systems.

    • Evidence generation – building the data to prove measurable impact on health and productivity
    • Scaling adoption – integrating precision nutrition into commercial production systems
    Speaker(s): 
    Panellists

    Author:

    Aaron Schacht

    CEO
    BiomEdit
    ... read more

    Aaron Schacht

    CEO
    BiomEdit
    Time: 
    3:15pm - 3:45pm
    Agenda Track No.: 
    Track 6
    Session Type: 
    General Session (Presentation)
    3:45pm - 4:00pm
    4:00pm - 4.20pm
    One-to-One Meetings + Next Stages

    Meeting Timeslot Twelve

    Time: 
    4:00pm - 4:20pm
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One: Navigating Growth and Valuation to Achieve the Right Exit

    Securing the right exit is critical to ensuring innovation achieves full market potential. Louise Grubb, Managing Director of TriviumVet, shares how the company balanced growth milestones, resisted low valuations, and leveraged regulatory success to secure the right partner at the right time to achieve sustainable scale post-acquisition.

    Session Topics: 
    Milestone - Acquisition
    Companion
    Feline
    Canine
    Cardiovascular
    Renal
    Pain
    Gastro
    Acquisition
    Exit
    Speaker(s): 

    Author:

    Louise Grubb

    CEO & Co-Founder
    TriviumVet
    ... read more

    Louise Grubb

    CEO & Co-Founder
    TriviumVet
    Time: 
    4:00pm - 4.20pm
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    4:00pm - 4.20pm
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    4:25pm - 4:45pm
    One-to-One Meetings + Next Stages

    Meeting Timeslot Thirteen

    Time: 
    4:25pm - 4:45pm
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One: Navigating Collaboration to Scale Veterinary Decision Support

    Partnerships can transform the trajectory of a health-tech startup. Johanna Majamaa, CEO of GekkoVet discusses how working with Royal Canin enabled the company to validate its platform across 100 clinics, demonstrate real-world impact, and lay the groundwork for expansion into new markets and universities.

    Session Topics: 
    Milestone - Collaboration
    Technology
    Partnerships
    Companion
    Veterinary
    Speaker(s): 

    Author:

    Johanna Majamaa

    Chief Executive Officer
    Gekko Vet Oy
    ... read more

    Johanna Majamaa

    Chief Executive Officer
    Gekko Vet Oy
    Time: 
    4:25pm - 4:45pm
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    4:25pm - 4:45pm
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    4.50pm - 5.10pm
    One-to-One Meetings + Next Stages

    Meeting Timeslot Fourteen

    Time: 
    4.50pm - 5.10pm
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One

    Time: 
    4.50pm - 5.10pm
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    4.50pm - 5.10pm
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    5.15pm - 5.35pm
    One-to-One Meetings + Next Stages

    Meeting Timeslot Fifteen

    Time: 
    5.15pm - 5.35pm
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One

    Time: 
    5.15pm - 5.35pm
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    5.15pm - 5.35pm
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    5.40pm - 6.00pm
    One-to-One Meetings + Next Stages

    Meeting Timeslot Sixteen

    Time: 
    5.40pm - 6.00pm
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One

    Time: 
    5.40pm - 6.00pm
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    5.40pm - 6.00pm
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    6.05pm - 6.25pm
    One-to-One Meetings + Next Stages

    Meeting Timeslot Seventeen

    Time: 
    6.05pm - 6.25pm
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One

    Time: 
    6.05pm - 6.25pm
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    6.05pm - 6.25pm
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    6:25pm - 7:25pm
    Social
    7:25pm onwards
    Social
  • Wed, Mar 4: Main Event: Wednesday, 4 Mar, 2026
    8:35am - 8:55am
    One-to-One Meetings + Next Stages

    Meeting Timeslot Eighteen

    Time: 
    8:35am - 8:55am
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One: Navigating Policy Shifts to Build a Commercial Pathway

    Regulatory change can make or break a startup’s trajectory overnight. Dr Angela Jones, co-founder of Petscribers shares how the UK Competition and Markets Authority’s investigation into the veterinary sector validated their vision, flipped investor sentiment, and drove veterinary interest. 

    Session Topics: 
    Milestone - Navigating Policy Change
    Prescriptions
    CMA
    Policy
    Customer Adoption
    Regulation
    Equine
    Companion
    Speaker(s): 

    Author:

    Dr Angela Jones

    Co-CEO
    Petscribers
    ... read more

    Dr Angela Jones

    Co-CEO
    Petscribers
    Time: 
    8:35am - 8:55am
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    8:35am - 8:55am
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    9:00am - 9:20am
    One-to-One Meetings + Next Stages

    Meeting Timeslot Nineteen

    Time: 
    9:00am - 9:20am
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One: Navigating Genetic Complexity to Achieve Practical On-Farm Adoption

    Genetic data holds enormous potential for livestock producers, but too often it’s locked behind complexity and technical barriers. Sean Akadiri, Founder & CEO of AgBoost, shares how the company translated science into practical, accessible tools that ranchers can use every day. Learn how this approach accelerated adoption across operations, built global partnerships, and proved the bottom-line value of user-driven innovation in livestock genetics. 

    Session Topics: 
    Milestone - On-Farm Adoption
    Data
    Genetics
    Technology
    Livestock
    Farmer
    Speaker(s): 

    Author:

    Sean Akadiri

    Founder & CEO
    AgBoost
    ... read more

    Sean Akadiri

    Founder & CEO
    AgBoost
    Time: 
    9:00am - 9:20am
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    9:00am - 9:20am
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    9.25am - 9.45am
    One-to-One Meetings + Next Stages

    Meeting Timeslot Twenty

    Time: 
    9.25am - 9.45am
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One: Navigating Alternatives to Traditional Go-to-Market Strategy to Achieve Early Market Entry

    Early market entry is often necessary to generate revenue and support the commercialisation of innovation. Jasdeep Singh, CEO of SingleTimeMicroneedles, explains how his company bridged the financing gap through navigating alternatives to traditional regulatory and go-to-market strategies.

    Session Topics: 
    Milestone - Regulatory Approval
    Biopharma
    Treatment
    Prevention
    Go-to-Market
    Companion and Livestock
    2025 Showcase Finalist
    Speaker(s): 

    Author:

    Jasdeep Singh

    CEO
    SingleTimeMicroneedles
    ... read more

    Jasdeep Singh

    CEO
    SingleTimeMicroneedles
    Time: 
    9.25am - 9.45am
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    9.25am - 9.45am
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    9.50am - 10.10am
    One-to-One Meetings + Next Stages

    Meeting Timeslot Twenty One

    Time: 
    9.50am - 10.10am
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One: Navigating AI and Real-World Data to Drive Breakthroughs in Veterinary Oncology

    Harnessing the power of real-world evidence is critical to scaling precision medicine. Christina Lopes, Co-Founder & CEO of FidoCure, shares how the company built a canine cancer dataset and leveraged AI to transform data points into targeted therapies, driving adoption beyond oncology specialists and enabling validated and scalable solutions.

    Session Topics: 
    Milestone - AI Breakthrough
    AI
    Data
    Oncology
    Precision Medicine
    Canine
    Speaker(s): 

    Author:

    Christina Lopes

    Co-Founder and CEO
    FidoCure
    ... read more

    Christina Lopes

    Co-Founder and CEO
    FidoCure
    Time: 
    9.50am - 10.10am
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    9.50am - 10.10am
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    10:10am - 10:25am
    10:25am - 12:25pm
    Plenaries

    Presentation

    Sponsor(s): 
    Elanco
    Speaker(s): 

    Author:

    Tim Bettington

    Executive Vice President, Corporate Strategy & Market Development
    Elanco
    ... read more

    Tim Bettington

    Executive Vice President, Corporate Strategy & Market Development
    Elanco
    Time: 
    10:30am - 10:50am
    Session Type: 
    General Session (Presentation)

    PANEL: AI & Data - Impact on Commercialisation Journeys and Health Outcomes

    Our panellists will discuss where data and AI are going to have the greatest impact on advancing health outcomes, the delivery of care and R&D.

    • AI’s impact on reducing the timeline between adoption of innovation in Human Health and Animal Health
    • Improving capital efficiency - rethinking the R&D process with AI
    • How common data structure and architecture design will facilitate industry collaboration and unleash the power of existing data
    • Improving differential diagnosis at point of care – augmenting, not replacing, practitioner decision making
    • Teaching future generations how to deliver care based on new and growing sources of data
    Speaker(s): 
    Panellists

    Author:

    Paul Higgs

    Chief Veterinary Officer
    CVS Group Plc
    ... read more

    Paul Higgs

    Chief Veterinary Officer
    CVS Group Plc
    Time: 
    10:55am - 11:25am
    Session Type: 
    General Session (Presentation)

    PANEL: Preventing and Managing Transboundary Animal Disease Outbreaks

    Transboundary animal diseases (TADs) such as avian influenza, bluetongue virus, and foot-and-mouth disease pose serious risks to animal health, livestock production, and public health. Past outbreaks have exposed gaps in disease awareness and preparedness, with farmers often bearing the greatest impact. Effective prevention, through international collaboration, biosecurity, vaccination, and surveillance, requires coordinated action to stop the spread and support eradication efforts.

    Sponsor(s): 
    Boehringer Ingelheim
    Speaker(s): 
    Panellists

    Author:

    Pascal Hudelet

    Head of Global Technical Service, Veterinary Public Health (VPH) Center
    Boehringer Ingelheim
    ... read more

    Pascal Hudelet

    Head of Global Technical Service, Veterinary Public Health (VPH) Center
    Boehringer Ingelheim
    Time: 
    11:30am - 12:00pm
    Session Type: 
    General Session (Presentation)

    PANEL: Next Generation Care Delivery – Integrating Products and Services for Connected Care

    From prevention to treatment, animal health companies are rethinking how products and services connect across the care journey. Industry leaders will discuss how integration is reshaping delivery models, improving outcomes, and setting new benchmarks for the continuum of care.

    • Building a sustainable competitive advantage through customer centricity
    • Applications of AI & Data that fundamentally change the pet owner experience
    • Practice workflows, service models and reaching the animal
    Speaker(s): 
    Panellists

    Author:

    Gudrun Ravetz

    Group Chief Medical Officer
    IVC Evidensia

    Currently Gudrun works as a Veterinary Consultant to Pet Health Plans from Denplan and as an external interviewer for prospective veterinary students at University of Liverpool. Alongside practicing as a small animal veterinary surgeon on graduating in 2002, Gudrun furthered her interest in the business side of the veterinary profession by studying for the post graduate certificate in business. Gudrun became President at the BVA Member’s Day and AGM on 22 September 2016.

    ... read more

    Gudrun Ravetz

    Group Chief Medical Officer
    IVC Evidensia

    Currently Gudrun works as a Veterinary Consultant to Pet Health Plans from Denplan and as an external interviewer for prospective veterinary students at University of Liverpool. Alongside practicing as a small animal veterinary surgeon on graduating in 2002, Gudrun furthered her interest in the business side of the veterinary profession by studying for the post graduate certificate in business. Gudrun became President at the BVA Member’s Day and AGM on 22 September 2016.

    Time: 
    12:05pm - 12:35pm
    Session Type: 
    General Session (Presentation)
    12:35pm - 1:35pm
    1:35pm - 2:40pm
    Plenaries

    PANEL: Commercialisation Journeys: Expanding Reach and Value Through Evolving Future Care Models.

    From generics to emerging technologies and distribution partnerships, innovative routes to market are expanding reach and reshaping the competitive landscape. Leaders share how new models are lowering barriers to entry, driving scale, accelerating time to market, and creating sustainable value across the ecosystem.

    Speaker(s): 
    Panellists

    Author:

    Steve Shell

    President
    MWI Animal Health
    ... read more

    Steve Shell

    President
    MWI Animal Health

    Author:

    Neeraj Agrawal

    Managing Director
    Felix Pharmaceuticals
    ... read more

    Neeraj Agrawal

    Managing Director
    Felix Pharmaceuticals
    Time: 
    1:35pm - 2:05pm
    Session Type: 
    General Session (Presentation)

    PANEL: Chronic Disease Management - Extending the Reach of Therapeutics Through Integrated Care

    From obesity to renal disease, chronic conditions remain some of the toughest challenges in veterinary medicine. Changemakers examine how next-generation therapeutics, supported by diagnostics and other modalities, can deliver sustainable results and change the way veterinarians manage long-term disease.

    Sponsor(s): 
    Zoetis
    Time: 
    2:10pm - 2:40pm
    Session Type: 
    General Session (Presentation)
    2:30pm - 2.50pm
    One-to-One Meetings + Next Stages

    Meeting Timeslot Twenty-Two

    Time: 
    2:30pm - 2:50pm
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One

    Time: 
    2.30pm - 2.50pm
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    2.30pm - 2.50pm
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    2.55pm - 3.15pm
    One-to-One Meetings + Next Stages

    Meeting Timeslot Twenty-Three

    Time: 
    2.55pm - 3.15pm
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One

    Time: 
    2.55pm - 3.15pm
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    2.55pm - 3.15pm
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    3.20pm - 3.40pm
    One-to-One Meetings + Next Stages

    Meeting Timeslot Twenty-Four

    Time: 
    3.20pm - 3.40pm
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One

    Time: 
    3.20pm - 3.40pm
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    3.20pm - 3.40pm
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    3.45pm - 4.05pm
    One-to-One Meetings + Next Stages

    Meeting Timeslot Twenty-Five

    Time: 
    3.45pm - 4.05pm
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One

    Time: 
    3.45pm - 4.05pm
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    3.45pm - 4.05pm
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    4.10pm - 4.30pm
    One-to-One Meetings + Next Stages

    Meeting Timeslot Twenty-Six

    Time: 
    4.10pm - 4.30pm
    Agenda Track No.: 
    Track 1
    Summary: 
    Want to prioritise meetings at this time? All Next Stage sessions will be recorded and available to watch on-demand
    Session Type: 
    General Session (Presentation)

    Next Stage One

    Time: 
    4.10pm - 4.30pm
    Agenda Track No.: 
    Track 2
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)

    Next Stage Two

    Time: 
    4.10pm - 4.30pm
    Agenda Track No.: 
    Track 3
    Summary: 
    Session Will be Recorded - Attend live or Watch On-Demand
    Session Type: 
    General Session (Presentation)
    4:30pm
    Close

Jump to: Monday, 2 Mar | Monday, 2 Mar | Tuesday, 3 Mar | Wednesday, 4 Mar

Agenda Tracks: 
Track Title: 
1-2-1 Meetings
Track Color: 
#46dacc
Track Title: 
Next Stage One
Track Color: 
#6ce430
Track Title: 
Next Stage Two
Track Color: 
#dd1dae
Track Title: 
Changemaker A
Track Color: 
#d9dbcf
Track Title: 
Changemaker B
Track Color: 
#95a1a0
Track Title: 
Changemaker C
Track Color: 
#585d5e
Track Title: 
Workshop Stream A
Track Color: 
#c1c3b6
Track Title: 
Workshop Stream B
Track Color: 
#807676
Track Title: 
Roundtable Stream A
Track Color: 
#eccaca
Track Title: 
Roundtable Stream B
Track Color: 
#e49d9d
Track Title: 
Investor Briefing
Track Color: 
#1a54c3
Track Title: 
Practice Group Briefing
Track Color: 
#ecdc15
Event Reference: 
AHNTI EU 2026